Ditchcarbon
  • Customers
  1. Organizations
  2. Alembic Pharmaceuticals
Public Profile
Pharmaceutical Preparation Manufacturing
IN
updated 10 days ago

Alembic Pharmaceuticals

Company website

Alembic Pharmaceuticals Limited, commonly referred to as Alembic, is a prominent player in the global pharmaceutical industry, headquartered in Vadodara, India. Established in 1907, the company has a rich history marked by significant milestones, including its expansion into regulated markets and the development of a robust portfolio of generic and branded formulations. Alembic operates primarily in the areas of pharmaceuticals, biotechnology, and active pharmaceutical ingredients (APIs), focusing on therapeutic segments such as cardiovascular, anti-infective, and central nervous system disorders. The company is renowned for its commitment to quality and innovation, which is reflected in its extensive range of products that meet stringent international standards. With a strong market position, Alembic Pharmaceuticals has achieved notable success, including multiple approvals from regulatory authorities worldwide. Its dedication to research and development, coupled with a strategic approach to global expansion, solidifies its reputation as a trusted name in the pharmaceutical sector.

DitchCarbon Score

How does Alembic Pharmaceuticals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

61

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Alembic Pharmaceuticals's score of 61 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.

78%

Let us know if this data was useful to you

Alembic Pharmaceuticals's reported carbon emissions

In 2024, Alembic Pharmaceuticals reported total greenhouse gas emissions of approximately 86096000 kg CO2e for Scope 1, 67544000 kg CO2e for Scope 2, and a significant 756174000 kg CO2e for Scope 3 emissions. This represents a comprehensive approach to emissions reporting, covering all three scopes. The company has set ambitious targets to reduce its greenhouse gas emissions, aiming for a 63% reduction by 2035 and a net-zero commitment by 2050. These targets are aligned with the Science Based Targets initiative (SBTi), which stipulates a 90% reduction in absolute emissions across all scopes by 2050, using 2022 as the base year. In 2023, Alembic Pharmaceuticals reported emissions of approximately 79194000 kg CO2e for Scope 1, 83482000 kg CO2e for Scope 2, and 644996000 kg CO2e for Scope 3. The company has demonstrated a commitment to sustainability through these disclosures and its long-term climate strategy. Alembic Pharmaceuticals' emissions data is not cascaded from any parent organization, indicating that the reported figures are independently sourced. The company is actively working towards its climate commitments, reflecting a strong dedication to reducing its environmental impact within the pharmaceutical sector.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2021202220232024
Scope 1
-
00,000,000
00,000,000
00,000,000
Scope 2
-
00,000,000
00,000,000
00,000,000
Scope 3
-
000,000,000
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Alembic Pharmaceuticals's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Alembic Pharmaceuticals is in IN, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Alembic Pharmaceuticals is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Lupin

IN
•
Pharmaceutical Preparation Manufacturing
Updated about 3 hours ago

Cipla

IN
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Innova Captab Ltd

IN
•
Pharmaceutical Preparation Manufacturing
Updated about 3 hours ago

Pfizer Limited

IN
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Akums Drugs and Pharmaceuticals Limited

IN
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Zydus Lifesciences

IN
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250807.7
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy